[DRAFT] Breast Implant Risk Management Framework

Overview

The Therapeutic Goods Administration (TGA) is seeking comments on a proposed Breast Implant Risk Management Framework. The draft framework describes how the TGA identify, communicate and manage the risks associated with breast implants and what patients can do. 

 

Why your views matter

The draft framework was developed to ensure that healthcare practitioners and patients have a shared understanding of the potential risks associated with breast implants, enabling informed decision making, enhanced patient safety and continuous improvement in breast implant-related procedures. We encourage you to share your feedback during this consultation. Your input is instrumental in refining the framework, and in ensuring that the framework reflects the needs and expectations of the public.

Closed 26 Mar 2024

Opened 27 Feb 2024

Audiences

  • Aged care professionals
  • Aged care service providers
  • Aged care workforce
  • Biologicals
  • Businesses
  • Commonwealth agencies
  • Community groups
  • Complementary medicines
  • Contracted Service Providers
  • General public
  • Health professionals
  • Health workforce
  • Industry
  • Local governments
  • Manufacturers
  • Medical Devices & IVDs
  • Non-government organisations
  • Other
  • Over-the-counter medicines
  • Prescription medicines
  • Sponsors
  • State government agencies